KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATFurniture, Fixtures and OtherGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares OutstandingShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Boston Scientific (BSX) Accumulated Depreciation & Amortization (2016 - 2026)

Boston Scientific's Accumulated Depreciation & Amortization history spans 18 years, with the latest figure at $351.0 million for Q1 2026.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 8.0% to $351.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $351.0 million, a 8.0% increase, with the full-year FY2025 number at $1.4 billion, up 7.8% from a year prior.
  • Accumulated Depreciation & Amortization hit $351.0 million in Q1 2026 for Boston Scientific, down from $1.4 billion in the prior quarter.
  • Over the last five years, Accumulated Depreciation & Amortization for BSX hit a ceiling of $1.4 billion in Q4 2025 and a floor of $274.0 million in Q1 2022.
  • Historically, Accumulated Depreciation & Amortization has averaged $739.6 million across 5 years, with a median of $661.0 million in 2025.
  • Biggest five-year swings in Accumulated Depreciation & Amortization: grew 2.24% in 2022 and later increased 8.9% in 2025.
  • Tracing BSX's Accumulated Depreciation & Amortization over 5 years: stood at $1.1 billion in 2022, then grew by 5.28% to $1.2 billion in 2023, then grew by 6.1% to $1.3 billion in 2024, then increased by 7.8% to $1.4 billion in 2025, then plummeted by 74.34% to $351.0 million in 2026.
  • Business Quant data shows Accumulated Depreciation & Amortization for BSX at $351.0 million in Q1 2026, $1.4 billion in Q4 2025, and $1.0 billion in Q3 2025.